Serotonin receptors as cardiovascular targets

Drug Discovery Today

Volumn 2, Issue 7, 1997, Pages 294-300

  Villalón, Carlos M ^a,b   De Vries, Peter ^a   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN RECEPTOR;

REVIEW;

EID: 0030820107     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(97)01055-6     Document Type: Review

References (70)

1. Weiss, O. (1896) Arch. Gesamte Physiol. Menschen Thiere 65, 215-230
2. Rummo, G. and Bordoni, L. (1889) Arch. Biol. Ital. 12, 46-47
3. Saxena, P.R. and Villalón, C.M. (1990) J. Cardiovasc. Pharmacol. 15 (Suppl. 7), S17-34
4. Saxena, P.R. (1995) Pharmacol. Ther. 66, 339-368
5. Rand, M.J. et al. (1987) J. Cardiovasc. Pharmacol. 10 (Suppl. 12), S33-44
6. Lincoln, J., Loesch, A. and Burnstock, G. (1990) Cell Tissue Res. 259, 341-344
7. Gaddum, J.H. and Picarelli, Z.P. (1957) Br. J. Pharmacol. 12, 323-328
8. Saxena, P.R. (1972) Headache 12, 44-54
9. Peroutka, S.J. and Snyder, S.H. (1979) Mol. Pharmacol. 16, 687-699
10. Van Nueten, J.M. et al. (1981) J. Pharmacol. Exp. Ther. 218, 217-230
11. Bradley, P.B. et al.(1986) Neuropharmacology 25, 563-576
12. Hoyer, D. et al. (1994) Pharmacol. Rev. 46, 157-203
13. Hartig, P.R. et al. (1996) Trends Pharmacol. Sci. 17, 103-105
14. Humphrey, P.P. et al. (1988) Br. J. Pharmacol. 94, 1123-1132
15. De Vries, P. et al. (1996) Br. J. Pharmacol. 118, 85-92
16. Villalón, C.M., Sánchez-López, A. and Centurión, D. (1996) Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 550-556
17. Villalón, C.M. et al. (1997) Br. J. Pharmacol. 120, 1319-1327
18. Saxena, P.R. and Villalón, C.M. (1991) Trends Pharmacol. Sci. 12, 223-227
19. Martin, G.R. (1994) Pharmacol. Ther. 62, 283-324
20. De Vries, P. et al. (1997) Naunyn-Schmiedeberg's Arch. Pharmacol. 355, 423-430
21. Villalón, C.M. et al. Br. J. Pharmacol. (in press)
22. Fozard, J.R., Mir, A.K. and Middlemiss, D.N. (1987) J. Cardiovasc. Pharmacol. 9, 328-347
23. Ramage, A.G. and Fozard, J.R. (1987) Eur. J. Pharmacol. 138, 179-191
24. Villalón, C.M. and Terrón, J.A. (1994) Br. J. Pharmacol. 113, 13-20
25. Molderings, G.J. et al. (1996) Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 272-280
26. Trevethick, M.A., Feniuk, W. and Humphrey, P.P. (1986) Life Sci. 38, 1521-1528
27. Fozard, J.R. (1995) Arch. Int. Pharmacodyn. Ther. 329, 111-119
28. Hamel, E. et al. (1993) Mol. Pharmacol. 44, 242-246
29. Bouchelet, I. et al. (1996) Mol. Pharmacol. 50, 219-223
30. Razzaque, Z. et al. (1997) Br. J. Pharmacol. 120, 211P
31. Robertson, J.I. (1990) Cardiovasc. Drugs Ther. 4 (Suppl. 1), 53-58
32. Robertson, J.I. (1991) J. Cardiovasc. Pharmacol. 17 (Suppl. 5), S48-53
33. Saxena, P.R. and Ferrari, M.D. (1996) Expert Opin. Invest. Drugs 5, 581-593
34. Humphrey, P.P. and Feniuk, W. (1991) Trends Pharmacol. Sci. 12, 444-446
35. Ferrari, M.D. and Saxena, P.R. (1993) Trends Pharmacol. Sci. 14, 129-133
36. MaassenVanDenBrink, M. et al. (1997) Br. J. Pharmacol. 120, 68P
37. Hoskin, K.L., Kaube, H. and Goadsby, P.J. (1996) Brain 119, 1419-1428
38. Moskowitz, M.A. (1992) Trends Pharmacol. Sci. 13, 307-311
39. Phebus, L.A. et al. (1996) Neuroscience Meeting 1996, Washington, DC, USA
40. Gupta, P. et al. (1995) Br. J. Pharmacol. 116, 2385-2390
41. Brändli, P. et al. (1996) Pain 64, 315-322
42. Shepheard, S.L. et al. (1995) Neuropharmacology 34, 255-261
43. Diener, H.C. for the RPR100893-201 migraine study group (1995) 6th International Headache Research Seminar 1995, Copenhagen, Denmark
44. Goldstein, D. (1996) Conference on Tachykinins and their Antagonists, London, UK
45. May, A. et al. (1996) Pain 67, 375-378
46. Roon, K. et al. (1997) International Headache Congress 1997, Amsterdam, The Netherlands
47. Adham, N. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 408-412
48. Yu, X-J. et al. (1997) Neuropharmacology 36, 83-91
49. Skingle, M. et al. (1996) Behav. Brain Res. 73, 157-161
50. Goldstein, J. et al. (1996) Cephalalgia 16, 497-502
51. Leysen, J.E. et al. (1996) Mol. Pharmacol. 50, 1567-1580
52. Tfelt-Hansen, P. and Saxena, P.R. (1993) in The Headaches (Olesen, J., Tfelt-Hansen, P. and Welch, K.M.A., eds), pp. 373-382, Raven Press
53. Kalkman, H.O. (1994) Life Sci. 54, 641-644
54. Fozard, J.R. and Kalkman, H.O. (1994) Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 225-229
55. Saxena, P.R. and Den Boer, M.O. (1991) J. Neurol. 238 (Suppl. 1), S28-35
56. Ferrari, M.D. (1991) J. Neurol. 238 (Suppl. 1), S53-56
57. Ferrari, M.D. et al. (1991) Pain 45, 283-291
58. De Vries, P. et al. (1997) International Headache Congress 1997, Amsterdam, The Netherlands
59. De Vries, P. et al. (1997) Naunyn-Schmiedeberg's Arch. Pharmacol. (in press)
60. Reneman, R.S. and van der Starre, P.J. (1990) Cardiovasc. Drugs Ther. 4 (Suppl. 1), 19-25
61. Van der Starre, P.J. and Reneman, R.S. (1994) J. Cardiothorac. Vasc. Anesth. 8, 455-462
62. Lebrec, D. (1990) Cardiovasc. Drugs Ther. 4 (Suppl. 1), 33-35
63. Weiner, C.P. (1990) Cardiovasc. Dnigs Ther. 4 (Suppl. 1), 37-43
64. Kaumann, A.J. (1994) Trends Pharmacol. Sci. 15, 451-455
65. Jahnel, U. et al. (1992) Naunyn-Schmiedeberg's Arch. Pharmacol. 346, 482-185
66. Schoemaker, R.G. et al. (1993) Eur. J. Pharmacol. 230, 103-105
67. Coffman, J.D. (1991) Hypertension 17, 593-602
68. Bielenberg, G.W. and Burkhardt, M. (1990) Stroke 21 (Suppl. 12), IV161-163
69. Bode-Greuel, K.M. et al. (1990) Stroke 21 (Suppl. 12), IV164-166
70. Silver, B., Weber, J. and Fisher, M. (1996) Clin. Neuropharmacol. 19, 101-128